The physiology of intercellular Signaling through gap junctions is still a mystery. In spite of considerable progress in connexin biochemistry, and genetics, the ligands that directly control whether the channels are open or closed are unknown. Identification of fhe cytoplasmic factors that interact directly with connexin channels, and how they modulate channel activity, are fundamental unsolved issues with far-reaching impact. Gap junction channels (composed of connexin) are regulated pathways for intercellular movement of ionsn and small molecules. Their location constrains their study in situ; both ends of the pore are intracellular, inaccessible to most used to explore channel function. Since access to the channel is via cytoplasm, it is difficult to identify factors that act directly on the channel, rather than via cellular components. The long-term goal is to understand the molecular operation of this pathway of intercellular signaling. The approach is to study connexin channels in a reconstituted system where their modulation can be readily explored. Channels formed by connexin32 and connexin26 immunopurified from native tissues and expression vectors will be studied in a well-characterized system that yields information that cellular studies cannot. The experiments build on preliminary studies that have identified, for the first time, compounds that interact directly and noncovalently with connexin channels to modulate their activity. The proposed studies address the questions: What is the molecular basis for the action of protonmated aminosulfonates such as taurine on connexin chanel activity? What is the molecular basis of the high-affinity inhibition of connexin channels by the high-affinity inhibition of connexin channels by cAMP and cGMP? What parts of connexin molecules interact with these compounds? Why do the two connexins respond differently? What can be learned about connexin structure-function when derivatives of these compounds are' used as affinity reagents? By study of connexin channels in this experimentally accessible system, one hopes to understand the fudamental properties of intercellular signaling. Gap junctions are so widespread that elucidation of connexin channel activity modulation will have profound consequences throughout cellular and developmental biology. There are over 18 known connexins. In humans, genetic defects in connexin32 cause a peripheral neuropathy, and in connexin26 cause a large fraction of nonsyndromic deafness. No doubt many other syndromes anise in toto or in part from defects in connexin channel function. Such defects will result in abnormal (i.e., greater or lesser) intercellular signaling molecules. The proposed studies address how this may occur.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM061406-01
Application #
2842277
Study Section
Special Emphasis Panel (ZRG1-MDCN-5 (02))
Program Officer
Nichols, Paul L
Project Start
1999-09-01
Project End
2003-08-31
Budget Start
1999-09-01
Budget End
2000-08-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Pharmacology
Type
Schools of Medicine
DUNS #
605799469
City
Newark
State
NJ
Country
United States
Zip Code
07107
Locke, Darren; Kieken, Fabien; Tao, Liang et al. (2011) Mechanism for modulation of gating of connexin26-containing channels by taurine. J Gen Physiol 138:321-39
Johnstone, Scott; Isakson, Brant; Locke, Darren (2009) Biological and biophysical properties of vascular connexin channels. Int Rev Cell Mol Biol 278:69-118
Locke, Darren; Harris, Andrew L (2009) Connexin channels and phospholipids: association and modulation. BMC Biol 7:52
Locke, Darren; Jamieson, Susan; Stein, Torsten et al. (2007) Nature of Cx30-containing channels in the adult mouse mammary gland. Cell Tissue Res 328:97-107
Tao, Liang; Harris, Andrew L (2007) 2-aminoethoxydiphenyl borate directly inhibits channels composed of connexin26 and/or connexin32. Mol Pharmacol 71:570-9
Ayad, Wafaa A; Locke, Darren; Koreen, Irina V et al. (2006) Heteromeric, but not homomeric, connexin channels are selectively permeable to inositol phosphates. J Biol Chem 281:16727-39
Locke, Darren; Koreen, Irina V; Harris, Andrew L (2006) Isoelectric points and post-translational modifications of connexin26 and connexin32. FASEB J 20:1221-3
Locke, Darren; Liu, Jade; Harris, Andrew L (2005) Lipid rafts prepared by different methods contain different connexin channels, but gap junctions are not lipid rafts. Biochemistry 44:13027-42
Tao, Liang; Harris, Andrew L (2004) Biochemical requirements for inhibition of Connexin26-containing channels by natural and synthetic taurine analogs. J Biol Chem 279:38544-54
Koreen, Irina V; Elsayed, Wafaa A; Liu, Yu J et al. (2004) Tetracycline-regulated expression enables purification and functional analysis of recombinant connexin channels from mammalian cells. Biochem J 383:111-9

Showing the most recent 10 out of 15 publications